Tranexamic Acid for Hyperpigmentation Disorders: A Literature Review on Efficacy and Safety in Melasma and PIH

Key Points

• Tranexamic acid indicates a favorable safety profile for treating hyperpigmentation disorders in dermatology, especially melasma.
• Clinicians observe its effectiveness across different routes of administration, suggesting versatile application.
• Literature review informs of its role as both a primary and adjunctive therapy, enhancing current treatment protocols.
• Efficacy with existing therapies highlights the potential for improved outcomes in dermatologic pigment management.

Abstract